ClinicalTrials.Veeva

Menu

Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

A

Ascension Macomb-Oakland Hospital

Status

Completed

Conditions

Preserved Ejection Fraction
Heart Failure

Treatments

Other: retrospective observation

Study type

Observational

Funder types

Other

Identifiers

NCT04008914
AscensionMacombOaklandH

Details and patient eligibility

About

Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.

Full description

Retrospective review of adults above the age of 18 with a primary diagnosis of HFpEF between August 2017 and March 2018. Subjects had to fall into one of two classifications (NYHA Class II-IV or ACC/AHA Stage B-D) and had a life expectancy greater than 6 months are included. Individuals with a terminal illness other than HF, prior heart transplant or on a transplant list, or current/ planned left ventricular assist device excluded. The primary objective of this study is to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.

Enrollment

492 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of Heart failure diagnosis admitted for treatment
  • Ejection fraction < 40% by echocardiogram

Exclusion criteria

  • Ejection fraction >40% by echocardiogram
  • Chronic Kidney disease requiring dialysis
  • Terminal illness
  • New onset diagnosis of Heart Failure

Trial design

492 participants in 2 patient groups

readmission at 30 days
Treatment:
Other: retrospective observation
readmission at 90 days
Treatment:
Other: retrospective observation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems